BIOGEN INC (NASDAQ: BIIB)

Overview
current price
$179.89
$179.89
change
3.71 | 2.11%
3.71 | 2.11%
Yesterday's Close
176.18
open
177.09
volume
1.49 M
30d. avg volume.
1.98 M
1 day
175.96 - 180.14
52 weeks
110.04 - 190.20
p/e
16.40
beta
0.1270
market cap
26.39 B
dividend yield
0.00%
Industry
-
News and Commentary
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US AstraZeneca plc (AZN&nb...
Only Half Of S&P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards? Despite a powerful 22% surge in the S&P 500 since the April lows-driven by easing U.S.-China trade tensions and a 90-day pause on new tariffs-only half of the index's stocks have...
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibod... On Tuesday, the FDA approved Eli Lilly and Co's (
Rising Stars, Falling Trends: July's Industry ETF Winners and Losers As July comes to an end, it's time to take a look at the best- and worst-performing industry ETFs for the month.Among the largest ETFs that represent ma...
Market Update: Dow Rallies 700 Points on Hopes Inflation is Easing Stocks staged their first rally of 2023 to close out the week higher on Friday after the December jobs report and other economic data showed signs that inflation may be cooling....
Biogen’s Alzheimer Drug Shows Promise in Key Study For the first time, a drug has been shown to
Market Update: Stocks Rebound from 2022 Low, Dow and S&P Snap Six-Day Losing Streak Stocks rose on Wednesday as U.S. Treasury yields retreated from multi-year highs. Benchmarks rebounded off bear market lows, with the Dow Jones Industrial Average jumping over 50...
Medicare to Reassess Premium Hike Meant to Cover Alzheimer Drug Costs Medicare is being asked by U.S. health secretary Xavier Becerra to
Market Update: Benchmarks Hit Record Closing Highs on Comeback Rally Wall Street benchmarks all reached record closing highs on Friday, rebounded from depressed levels in the previous session as market participants shook off concern over global ec...
FDA Grants Approval to Biogen's Alzheimer's Treatment, Met with Controversy Biogen's (BIIB 
StockTwits
StockTwits

Join now and unlock premium features